Quotes Spero Therapeutics, Inc. Börse Stuttgart
Stocks
2HA
US84833T1034
Biotechnology & Medical Research
|
Market Closed -
Börse Stuttgart
15:55:14 2026-10-09 EDT
|
5-day change | 1st Jan Change | ||
| 1.056 EUR | +5.28% |
|
-9.96% | -47.38% |
| 08-12 | Spero Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | Spero Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Stock exchange
Quotes 5-day view: Spero Therapeutics, Inc.
Delayed Quote Börse Stuttgart
| 2026-10-05 | 2026-10-06 | 2026-10-07 | 2026-10-08 | 2026-10-09 | |
|---|---|---|---|---|---|
| Last | €1.027 | €1.041 | €1.029 | €1.003 | €1.056 |
| Volume | 0 | 500 | 0 | 500 | 0 |
| Change | -2.10% | +1.36% | -1.15% | -2.53% | +5.28% |
| Opening | €1.036 | €1.010 | €1.032 | €1.018 | €1.001 |
| High | €1.075 | €1.062 | €1.067 | €1.064 | €1.065 |
| Low | €1.027 | €1.010 | €1.029 | €1.003 | €1.001 |
Performance
| 1 week | +0.67% | ||
| Current month | -0.47% | ||
| 1 month | +5.49% | ||
| 3 months | -42.98% | ||
| 6 months | -55.10% | ||
| Current year | -44.60% | ||
| 1 year | -44.94% | ||
| 3 years | -0.19% | ||
| 5 years | -92.62% |
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (EUR)
66,387,702
Market Cap (USD)
66,387,702
Net sales (USD)
47,977,000
Free-Float
77.34%
Free-Float capitalization (EUR)
57,488,430
Free-Float capitalization (USD)
51,342,917
Average Daily Capital Traded
-.--%
Indicators
Moving average 5 days
1.03
Moving average 20 days
1.032
Moving average 50 days
1.037
Moving average 100 days
1.468
Price spread / (MMA5)
-2.48%
Price spread / (MMA20)
-2.23%
Price spread / (MMA50)
-1.84%
Price spread / (MMA100)
+38.99%
RSI 9 days
46.5
RSI 14 days
46.92
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.28% | -9.96% | -44.94% | -0.19% | 66.39M | |
| -2.59% | -5.70% | +40.86% | +83.11% | 72.13B | |
| +3.23% | -10.67% | +4.87% | +55.97% | 49.41B | |
| +1.56% | +1.17% | +5.15% | +33.38% | 47.24B | |
| +0.87% | -8.17% | +298.53% | +645.03% | 40.32B | |
| +0.39% | +0.65% | +28.02% | +30.24% | 42.61B | |
| +1.24% | -1.01% | +5.56% | +105.14% | 39.81B | |
| -2.13% | -2.18% | +7.51% | +50.31% | 30.52B | |
| +5.32% | +0.06% | -7.20% | -11.30% | 23.13B | |
| +3.78% | +8.33% | +18.40% | +0.33% | 21.09B | |
| Average | +1.30% | -3.91% | +35.68% | +99.20% | 36.63B | |
| Weighted average by Cap. | +0.78% | -4.28% | +47.31% | +117.66% |
Historical Quotes: Spero Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 1 week | 1 |  | 1.08 |
| 1 month | 0.95 | | 1.22 |
| 3 years | 0.49 | | 2.6 |
| 5 years | 0.49 | | 15.6 |
Monthly variations
Annual variations
| 2026 | -44.60% | ||
| 2025 | +98.96% | ||
| 2024 | -25.79% | ||
| 2023 | -18.14% | ||
| 2022 | -88.14% | ||
| 2021 | -18.90% | ||
| 2020 | +79.23% |
- Stock Market
- Stocks
- SPRO Stock
- 2HA Stock
- Quotes Spero Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
